MDR Bacteremia in the Critically Ill During COVID-19: The MARTINI Study
Pathogens · 12.11.2025 · 14 (11) · 1152
DOI: 10.3390/pathogens14111152 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pathogens, online erschienen am 12.11.2025. Verfasst von Karolina Akinosoglou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: COVID-19, Bacteremia, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug-resistant (MDR) bloodstream infections (BSIs) constitute a major challenge in intensive care units, with the COVID-19 pandemic compromising infection control and potentially increasing MDR incidence. Comparative data between COVID and non-COVID ICU populations remain limited. The MARTINI study is a retrospective observational analysis held in a tertiary hospital during the COVID-19 pandemic (2020–2022) encompassing adult patients with MDR BSIs admitted to COVID and non-COVID ICUs. Demographics, comorbidities, severity scores, microbiology, resistance patterns, and outcomes were accessed and compared. A binary logistic regression model and multivariate regression was performed to identify independent predictors of ICU mortality. Among the study’s 156 patients (106 COVID-ICU, 50 non-COVID-ICU), COVID-ICU patients were significantly older with higher comorbidity and severity scores. Gram-negative pathogens predominated in both cohorts, mainly Acinetobacter baumannii and Klebsiella pneumoniae, with comparable resistance mechanisms. Timing of bacteremia onset and initiation of appropriate therapy did not differ between groups. However, ICU mortality was markedly higher in COVID-ICU patients (74.5% vs. 38%, p < 0.001). Age, SOFA score, the presence of systemic inflammation (SIRS) and COVID-19 infection were identified as independent predictors of mortality. Although pathogen distribution and resistance were similar across groups, COVID-ICU patients experienced significantly poorer outcomes. Strengthened infection control and timely and targeted antimicrobial therapy are essential to diminish MDR bacteremia risk in critically ill populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Patras, 26504 Patras, Greece.
- Department of Internal Medicine, University General Hospital of Patras, 26504 Patras, Greece.
- Division of Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece.
- Department of Tourism Management, University of Patras, 26504 Patras, Greece.
- Intensive Care Unit, University General Hospital of Patras, 26504 Patras, Greece.
- Department of Microbiology, University General Hospital of Patras, 26504 Patras, Greece.
ORCID-Profile: Karolina Akinosoglou, Dimitrios Bousis, Fevronia Kolonitsiou, George Dimopoulos
Zitieren
APA
Akinosoglou, K., Petropoulou, C., Karioti, V., Kefala, S., Bousis, D., Stamouli, V., Kolonitsiou, F., Dimopoulos, G., Gogos, C., & Fligou, F. (2025). MDR Bacteremia in the Critically Ill During COVID-19: The MARTINI Study. Pathogens, 14(11), 1152. https://doi.org/10.3390/pathogens14111152
Vancouver
Akinosoglou K, Petropoulou C, Karioti V, Kefala S, Bousis D, Stamouli V, et al. MDR Bacteremia in the Critically Ill During COVID-19: The MARTINI Study. Pathogens. 2025;14(11):1152. doi:10.3390/pathogens14111152
BibTeX
@article{Akinosoglou2025,
author = {Akinosoglou, Karolina and Petropoulou, Christina and Karioti, Vasiliki and Kefala, Sotiria and Bousis, Dimitrios and Stamouli, Vasiliki and Kolonitsiou, Fevronia and Dimopoulos, George and Gogos, Charalambos and Fligou, Foteini},
title = {MDR Bacteremia in the Critically Ill During COVID-19: The MARTINI Study},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {11},
pages = {1152},
doi = {10.3390/pathogens14111152}
}
EUVIMED